Anti-idiotype antibodies in cancer treatment

Autores
Alonso, Daniel Fernando; Vázquez, Ana María; Alonso, Daniel Fernando; Macías, Amparo
Año de publicación
2013
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Anti-idiotype antibodies (anti-Id Abs) are antibodies to idiotopes that are located in the variable region, including the antigen binding site, of another antibody. When the last is the case, these anti-Id Abs can act as surrogates of the original antigen. The capability of anti-Id Abs to modulate the immune response has been the basis for the development of anti-Id vaccines against different antigens, including tumor-associated antigens. Over the years, its use in cancer has been demonstrated as effective and promising.
Fil: Alonso, Daniel Fernando. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología. Laboratorio de Oncología Molecular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Vázquez, Ana María. No especifíca;
Fil: Alonso, Daniel Fernando. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología. Laboratorio de Oncología Molecular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Macías, Amparo. No especifíca;
Materia
Anti-Idiotype Antibodies
Cancer Treatment
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/3241
Acceder
id CONICETDig_67df59d9f6dfd552944dbed8f4fc0dc9
oai_identifier_str oai:ri.conicet.gov.ar:11336/3241
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Anti-idiotype antibodies in cancer treatmentAlonso, Daniel FernandoVázquez, Ana MaríaAlonso, Daniel FernandoMacías, AmparoAnti-Idiotype AntibodiesCancer Treatmenthttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3https://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Anti-idiotype antibodies (anti-Id Abs) are antibodies to idiotopes that are located in the variable region, including the antigen binding site, of another antibody. When the last is the case, these anti-Id Abs can act as surrogates of the original antigen. The capability of anti-Id Abs to modulate the immune response has been the basis for the development of anti-Id vaccines against different antigens, including tumor-associated antigens. Over the years, its use in cancer has been demonstrated as effective and promising.Fil: Alonso, Daniel Fernando. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología. Laboratorio de Oncología Molecular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Vázquez, Ana María. No especifíca;Fil: Alonso, Daniel Fernando. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología. Laboratorio de Oncología Molecular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Macías, Amparo. No especifíca;Frontiers Media S.A.2013-02-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/3241Alonso, Daniel Fernando; Vázquez, Ana María; Alonso, Daniel Fernando; Macías, Amparo; Anti-idiotype antibodies in cancer treatment; Frontiers Media S.A.; Frontiers in Oncology; 3; 26-2-2013; 12234-943Xenginfo:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fonc.2013.00037/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2013.00037info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581801/info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:52:58Zoai:ri.conicet.gov.ar:11336/3241instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:52:58.521CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Anti-idiotype antibodies in cancer treatment
title Anti-idiotype antibodies in cancer treatment
spellingShingle Anti-idiotype antibodies in cancer treatment
Alonso, Daniel Fernando
Anti-Idiotype Antibodies
Cancer Treatment
title_short Anti-idiotype antibodies in cancer treatment
title_full Anti-idiotype antibodies in cancer treatment
title_fullStr Anti-idiotype antibodies in cancer treatment
title_full_unstemmed Anti-idiotype antibodies in cancer treatment
title_sort Anti-idiotype antibodies in cancer treatment
dc.creator.none.fl_str_mv Alonso, Daniel Fernando
Vázquez, Ana María
Alonso, Daniel Fernando
Macías, Amparo
author Alonso, Daniel Fernando
author_facet Alonso, Daniel Fernando
Vázquez, Ana María
Macías, Amparo
author_role author
author2 Vázquez, Ana María
Macías, Amparo
author2_role author
author
dc.subject.none.fl_str_mv Anti-Idiotype Antibodies
Cancer Treatment
topic Anti-Idiotype Antibodies
Cancer Treatment
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Anti-idiotype antibodies (anti-Id Abs) are antibodies to idiotopes that are located in the variable region, including the antigen binding site, of another antibody. When the last is the case, these anti-Id Abs can act as surrogates of the original antigen. The capability of anti-Id Abs to modulate the immune response has been the basis for the development of anti-Id vaccines against different antigens, including tumor-associated antigens. Over the years, its use in cancer has been demonstrated as effective and promising.
Fil: Alonso, Daniel Fernando. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología. Laboratorio de Oncología Molecular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Vázquez, Ana María. No especifíca;
Fil: Alonso, Daniel Fernando. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología. Laboratorio de Oncología Molecular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Macías, Amparo. No especifíca;
description Anti-idiotype antibodies (anti-Id Abs) are antibodies to idiotopes that are located in the variable region, including the antigen binding site, of another antibody. When the last is the case, these anti-Id Abs can act as surrogates of the original antigen. The capability of anti-Id Abs to modulate the immune response has been the basis for the development of anti-Id vaccines against different antigens, including tumor-associated antigens. Over the years, its use in cancer has been demonstrated as effective and promising.
publishDate 2013
dc.date.none.fl_str_mv 2013-02-26
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/3241
Alonso, Daniel Fernando; Vázquez, Ana María; Alonso, Daniel Fernando; Macías, Amparo; Anti-idiotype antibodies in cancer treatment; Frontiers Media S.A.; Frontiers in Oncology; 3; 26-2-2013; 1
2234-943X
url http://hdl.handle.net/11336/3241
identifier_str_mv Alonso, Daniel Fernando; Vázquez, Ana María; Alonso, Daniel Fernando; Macías, Amparo; Anti-idiotype antibodies in cancer treatment; Frontiers Media S.A.; Frontiers in Oncology; 3; 26-2-2013; 1
2234-943X
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fonc.2013.00037/full
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2013.00037
info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581801/
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Frontiers Media S.A.
publisher.none.fl_str_mv Frontiers Media S.A.
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269191944536064
score 13.13397

Publicaciones similares